A comment piece by the redoubtable Ellen t'Hoen in this week's Lancet illustrates exactly the bind that the pharma industry finds itself in when trying to improve access to medicines in poorer countries. The piece reviews a judgement by the Indian Patent Office to reverse an earlier decision and grant the U.S. company Gilead a patent for Sovaldi … [Read more...] about The pharma industry’s access Catch-22
Surprisingly little reaction to coverage in The Guardian of a Development Initiatives report which suggests at least a fifth of bilateral official development assistance (ODA) in 2011 was never transferred to poor countries - the money was either spent on debt relief or within the donor countries themselves. While few would be surprised to see … [Read more...] about Keeping ODA at home – some surprising candidates
A recent report from the World Bank, The Challenge of Non-Communicable Diseases and Road Traffic Injuries in Sub-Saharan Africa, says that traffic accidents will be the leading killer of sub-Saharan African children aged 5-15 by 2015. The report points out that "for some [sub-Saharan African] countries, such as Mauritius and the Seychelles, and … [Read more...] about NCDs and traffic deaths in Africa: fated to remain the poor cousins of infectious disease?
The latest report from the AU and UNAIDS on African governments' spending on health makes depressing reading. It was produced as part of the Abuja+12 meeting held in the eponymous Nigerian capital last week to look at progress since the original Declaration made in 2001. A key commitment of the 2001 Abuja Declaration was the commitment to … [Read more...] about Slow progress in getting African tax revenues into health